跳到內容

婦產科

子宮收縮劑(Uterotonic Agents)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (開啟新視窗)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

出處‎: Cochrane Database Syst Rev 2018;4:CD011689.

檢索‎: PubMed 29693726

DOI碼‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (開啟新視窗)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (開啟新視窗)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

出處‎: Am J Obstet Gynecol.

檢索‎: PubMed 34534498

DOI碼‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (開啟新視窗)

Prophylactic use of ergot alkaloids in the third stage of labour. (開啟新視窗)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

出處‎: Cochrane Database Syst Rev 2007;(2):CD005456.

檢索‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (開啟新視窗)

Treatment for primary postpartum haemorrhage. (開啟新視窗)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

出處‎: Cochrane Database Syst Rev 2014;(2):CD003249.

檢索‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (開啟新視窗)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (開啟新視窗)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

出處‎: Int J Gynaecol Obstet 2014;127(2):175-9.

檢索‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (開啟新視窗)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (開啟新視窗)

Ragab A, Barakat R, Alsammani MA.

出處‎: Int J Gynaecol Obstet 2016;132(1):82-4.

檢索‎: PubMed 26522140

DOI碼‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (開啟新視窗)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (開啟新視窗)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

出處‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

檢索‎: PubMed 21775840

DOI碼‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (開啟新視窗)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (開啟新視窗)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

出處‎: Lancet Glob Health. 2023 11(2):e287-e295.

檢索‎: PubMed 36669809

DOI碼‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (開啟新視窗)

Intravenous sulprostone infusion in the treatment of retained placenta. (開啟新視窗)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

出處‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

檢索‎: PubMed 22862433

DOI碼‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (開啟新視窗)

Carbetocin for preventing postpartum haemorrhage. (開啟新視窗)

Su LL, Chong YS, Samuel M.

出處‎: Cochrane Database Syst Rev 2012;(4):CD005457.

檢索‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (開啟新視窗)

Prostaglandins for preventing postpartum haemorrhage. (開啟新視窗)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

出處‎: Cochrane Database Syst Rev 2012;(8):CD000494.

檢索‎: PubMed 22895917

DOI碼‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (開啟新視窗)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (開啟新視窗)

Westhoff G, Cotter AM, Tolosa JE.

出處‎: Cochrane Database Syst Rev 2013;(10):CD001808.

檢索‎: PubMed 24173606

DOI碼‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (開啟新視窗)